vTv Therapeutics (VTVT) Reports Q2 Loss of $0.47/Share

August 16, 2016 7:28 AM EDT
Get Alerts VTVT Hot Sheet
Price: $5.19 +0.97%

Today's EPS Names:
GCO, ALCO, BIG, More
Trade VTVT Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.47). Revenue for the quarter came in at $182 thousand, versus $110 thousand reported last year.

Cash, cash equivalents and marketable securities as of June 30, 2016 were $63.8 million, compared to $88.0 million as of December 31, 2015. The Company expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operations through at least mid-2017.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment